{"@type": "dcat:Dataset", "accessLevel": "public", "bureauCode": ["009:20"], "contactPoint": {"@type": "vcard:Contact", "fn": "VaxView Team", "hasEmail": "mailto:VaxView@cdc.gov"}, "description": "Monthly Cumulative Percent of Children <8 Months Who Received Nirsevimab by Jurisdiction, United States. \nNirsevimab coverage for children 0 to 7 months is assessed through U.S. jurisdictions\u2019 Immunization Information Systems Resources (IIS) data, submitted from jurisdictions to CDC monthly in aggregate by age group (https://www.cdc.gov/iis/about/).", "distribution": [{"@type": "dcat:Distribution", "downloadURL": "https://data.cdc.gov/api/v3/views/4bdk-kyzv/export.csv?accessType=DOWNLOAD", "mediaType": "text/csv"}, {"@type": "dcat:Distribution", "downloadURL": "https://data.cdc.gov/api/v3/views/4bdk-kyzv/query.json?accessType=DOWNLOAD", "mediaType": "application/json"}, {"@type": "dcat:Distribution", "downloadURL": "https://data.cdc.gov/api/v3/views/4bdk-kyzv/query.xml?accessType=DOWNLOAD", "mediaType": "application/xml"}], "identifier": "https://data.cdc.gov/api/views/4bdk-kyzv", "issued": "2024-11-20", "keyword": ["iis", "iqvia", "nis-acm", "rsv vaccination", "vsd"], "landingPage": "https://www.cdc.gov/vaccines/data-reporting/", "language": ["English"], "license": "https://www.usa.gov/government-works", "modified": "2026-07-30", "programCode": ["009:020"], "publisher": {"@type": "org:Organization", "name": "Centers for Disease Control and Prevention"}, "spatial": "United States- National", "theme": ["Vaccinations"], "title": "Monthly Cumulative Number and Percent of Children <8 Months Who Received Nirsevimab by Jurisdiction, United States"}